Explanation
BACKGROUND: The need exists to enter into an Enterprise Zone Agreement with the Boehringer Ingelheim Roxane, Inc. and it's US Affiliated Companies (Roxane Labs). The Ohio Enterprise Zone law O.R.C. Section 5709.62 (3) requires the City to enter into a Council-approved agreement between the City and participating companies.
The Department of Development is proposing to enter into an Enterprise Zone Agreement with Boehringer Ingelheim Roxane, Inc. and its U.S. Affiliated Companies to provide therewith an exemption of one-hundred percent (100%) on real property improvements for a term of fifteen (15) taxable years in consideration of the proposed investment of $41.2 million in real property improvements and the retention of 948 full-time permanent positions.
Roxane Labs is a subsidiary of Boehringer Ingelheim, one of the world's leading pharmaceutical companies. The parent company, headquartered in Ingelheim, Germany, is privately owned and currently has over 41,000 employees and 138 affiliated companies located throughout the world.
Boehringer Ingelheim is research driven and dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products.
Roxane Labs is proposing to expand its Columbus Wilson Road Campus facility by renovating an existing 60,000 square foot building and constructing a 23,600 square foot addition for its High Containment Operations. The project plans to close the Oak St. location and relocate the 46 employees to Wilson Road. The company is also considering other locations outside Ohio for this expansion.
Emergency action is requested of City Council in order to accommodate a project start date.
The Hilliard School District, pursuant to Ohio Revised Code 5709.62(D)(1), has approved the 100%/15 year abatement for Roxane Labs.
FISCAL IMPACT: No funding is required for this legislation.
Title
To authorize the Director of the Dep...
Click here for full text